Semiconductor News & Analysis Feed

www.rdworldonline.com Performing security verification This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot. Ray ID: a10b7b284905d6dc Performance and Security by Cloudflare Privacy

Mario Aguilar/STAT By Mario Aguilar June 11, 2026 Health Tech Correspondent NEW YORK — Health care artificial intelligence company Abridge on Thursday announced new deals with two trillion-dollar companies, pharma giant Eli Lilly and chipmaker Nvidia, as it aims to gain an edge in the competitive market that supports doctors and streamlines hospital billing and operations. Draped head-to-toe

__fail__

Nvidia offered investors a nearly certain path to gains over the past few years. As the leader in the artificial intelligence (AI) chip market, the company generated explosive revenue growth, and its innovation suggested that this momentum could keep on going over time. As a result, investors piled into the stock, and it rose more than 400% over the past three years. Pharmaceutical giant Eli Lill

__fail__

__fail__